Bad Homburg, 3.11.2021 – Creathor Ventures announced that the trans-atlantic private equity healthcare specialist ArchiMed has purchased a majority stake in Monheim, Germany-based Cube Biotech GmbH. Founded with an early-stage investment by Creathor Ventures in 2012, Cube has developed proprietary methods and products to provide high purity, stable membrane proteins for drug discovery. Membrane proteins are found across the surface of cells, playing a key role as receptors for drugs, but they are extremely difficult to extract without loss of native functionality. Stable extraction of such proteins is Cube’s core specialty and a critical step for successful structure determination and effective drug discovery.
Click here to read the press release
